2 active not recruiting, 2 not yet recruiting. 1 Not applicable, 1 Phase 2, 1 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Not yet recruiting 1 |
| Phase 2 | 1 | Not yet recruiting 1 |
| Phase 3 | 1 | Not yet recruiting 1 |
| Phase 4 | 1 | Active not recruiting 1 |
Follow Firsekibart: new trials by email Literature Review of Firsekibart trials Research Report on Firsekibart
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Immunoglobulin Plus Firsekibart in Patients With Kawasaki Disease IVIG, Aspirin, Firsekibart - Kawasaki Disease | Phase 2 / Phase 3 | Not yet recruiting | Children's Hospital of Fudan University | 90 | 2026-11-01 | 2026-10-22 |
| Efficacy and Safety of IL-1 Inhibitors in Mild to Moderate Systemic Lupus Erythematosus Firsekibart - Lupus Erythematosus, Systemic | Phase 4 | Active not recruiting | Chinese SLE Treatment And Research Group | 15 | 2026-06-16 | 2026-07-15 |
| 24-Week Recurrence Rate of Gout Following Firsekibart Treatment Firsekibart - Gout Flare | Not applicable | Not yet recruiting | Second Affiliated Hospital, Zhejiang University, School of Medicine | 264 | 2026-05-07 | 2026-06-04 |
| A Study of Firsekibart Versus Anakinra in Adult-Onset Still's Disease Firsekibart, Anakinra - Still's Disease, Adult-Onset | Active not recruiting | Ruijin Hospital | 20 | 2025-09-24 | 2026-10-16 |
Lupus Erythematosus, Systemic (1) · Mucocutaneous Lymph Node Syndrome (1)
Children's Hospital of Fudan University (1) · Chinese SLE Treatment And Research Group (1) · Ruijin Hospital (1) · Second Affiliated Hospital, Zhejiang University, School of Medicine (1)
China (4)
Fang Liu, MD (1)